An exploratory cross-sectional study of immune checkpoint inhibitors and immuno-related adverse events: Knowledge and influencing factors among Japanese oncology nurses-Reference-Cited by-同舟云学术

An exploratory cross-sectional study of immune checkpoint inhibitors and immuno-related adverse events: Knowledge and influencing factors among Japanese oncology nurses

Published:2023-01 Issue:1 Volume:10 Page:100147
ISSN:2347-5625
Container-title:Asia-Pacific Journal of Oncology Nursing
language:en
Short-container-title:Asia-Pacific Journal of Oncology Nursing

Author:

Tsuji Mikiko^ORCID,Hayashi Naoko^ORCID

Funder

Government of Japan Ministry of Education Culture Sports Science and Technology

Japan Society for the Promotion of Science

Publisher

Elsevier BV

Subject

Oncology (nursing),Oncology

Reference25 articles.

1. Guidelines for Cancer Immunotherapy,2019

2. Immune checkpoint inhibitor toxicities: systems-based approaches to improve patient care and research;Johnson;Lancet Oncol,2020

4. Immune-related adverse events of immune checkpoint inhibitors;Tadano;Nihon Rinsho Meneki Gakkai Kaishi,2017

5. Management of immunotherapy-related toxicities, version 1.2019, NCCN clinical practice guidelines in oncology;Thompson;J Natl Compr Cancer Netw,2019

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Experience of Chinese oncology nurses in providing care for patients with cutaneous toxicity of immunotherapy: A qualitative study;2024-02-05

2. Online patient attitudes towards cutaneous immune-related adverse events attributed to nivolumab and pembrolizumab: a sentiment analysis of drugs.com (Preprint);2023-10-18

3. Immune-related adverse events and immune checkpoint inhibitors: a focus on neurotoxicity and clinical management;Expert Review of Clinical Pharmacology;2023-05-04